Jacob J Abou-Hanna1, Amanda N Leggett2, Chris A Andrews3,4, Joshua R Ehrlich3,4. 1. University of Michigan Medical School, Ann Arbor, Michigan, USA. 2. Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan, USA. 3. Department of Ophthalmology and Visual Sciences, Center for Eye Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA. 4. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.
Abstract
OBJECTIVES: To investigate the association between visual impairment (VI) and depression in low- and middle-income countries (LMICs) and the mediating role of disability and social participation. METHODS/ DESIGN: The World Health Organization Study on global AGEing and adult health (SAGE) provided data on objective and subjective visual function, depression, disability (WHODAS-12), and social participation for nationally representative samples of adults 50 years and older in China, India, Ghana, Mexico, Russia, and South Africa. Multivariable logistic and linear models were used to test the association between VI and depression and the indirect pathways through disability and social participation. Analyses were adjusted for sociodemographics, medical comorbidities, and complex survey design features. RESULTS: Visual acuity was worse in respondents with depression compared to those without depression in China (0.32 vs 0.23 logMAR; P < .001), Ghana (0.26 vs 0.18 logMAR; P < .001), and India (0.36 vs 0.30 logMAR; P < .001); self-reported vision was also significantly worse in these three countries, but not in Mexico, Russia, or South Africa. Greater disability significantly mediated the association of both objective and self-reported VI with depression in China and India. Social participation significantly mediated the association between subjective vision and depression in Ghana. CONCLUSIONS: There is variability in the association between VI and depression across LMICs and in the mediating role of disability and social participation. Culture-specific instruments may be needed to better characterize the association between VI and depression and further research is needed to assess causality.
OBJECTIVES: To investigate the association between visual impairment (VI) and depression in low- and middle-income countries (LMICs) and the mediating role of disability and social participation. METHODS/ DESIGN: The World Health Organization Study on global AGEing and adult health (SAGE) provided data on objective and subjective visual function, depression, disability (WHODAS-12), and social participation for nationally representative samples of adults 50 years and older in China, India, Ghana, Mexico, Russia, and South Africa. Multivariable logistic and linear models were used to test the association between VI and depression and the indirect pathways through disability and social participation. Analyses were adjusted for sociodemographics, medical comorbidities, and complex survey design features. RESULTS: Visual acuity was worse in respondents with depression compared to those without depression in China (0.32 vs 0.23 logMAR; P < .001), Ghana (0.26 vs 0.18 logMAR; P < .001), and India (0.36 vs 0.30 logMAR; P < .001); self-reported vision was also significantly worse in these three countries, but not in Mexico, Russia, or South Africa. Greater disability significantly mediated the association of both objective and self-reported VI with depression in China and India. Social participation significantly mediated the association between subjective vision and depression in Ghana. CONCLUSIONS: There is variability in the association between VI and depression across LMICs and in the mediating role of disability and social participation. Culture-specific instruments may be needed to better characterize the association between VI and depression and further research is needed to assess causality.
Authors: Paul Mick; Maksim Parfyonov; Walter Wittich; Natalie Phillips; Dawn Guthrie; M Kathleen Pichora-Fuller Journal: Can Fam Physician Date: 2018-01 Impact factor: 3.275
Authors: Henry D Jampel; Kevin D Frick; Nancy K Janz; Patricia A Wren; David C Musch; Rajiv Rimal; Paul R Lichter Journal: Am J Ophthalmol Date: 2007-06-11 Impact factor: 5.258
Authors: Ruth M A van Nispen; Hilde L Vreeken; Hannie C Comijs; Dorly J H Deeg; Ger H M B van Rens Journal: Acta Ophthalmol Date: 2015-11-06 Impact factor: 3.761